A leading provider of
innovative DNA Screening solutions
TEL/AML1 Translocation, Dual Fusion LPH012
The TEL/ AML1 fusion gene is brought about by the cytogenetically invisible t(12;21) translocation. The rearrangement is the most common in childhood B-ALL and has been detected using FISH in around 21% of cases, compared to a pick-up rate of 0.05% by conventional cytogenetics. The translocation is associated with a favourable outcome though it has also been implicated with late relapse. Both the TEL1 and AML1 genes encode transcription factors but TEL1 has been shown to be required specifically for completing transcription during haematopoiesis within bone marrow.
TEL/AML1 Translocation, Dual Fusion Probe
Cat. No. LPH 012-S (5 tests)
Cat. No. LPH 012 (10 tests)
This webpage could contain information on product details or information not valid in your country or region. Please be aware that we do not take any responsibility for accessing such information, which may not comply with any legal process, regulation, registration or usage in the country of your origin. If you are a resident of a country other than those to which this site is directed, contact your local Cytocell distributor to obtain the appropriate product information for your country of residence.
Developed &produced in the UK